期刊
CHEMISTRY AND PHYSICS OF LIPIDS
卷 164, 期 6, 页码 590-606出版社
ELSEVIER IRELAND LTD
DOI: 10.1016/j.chemphyslip.2011.04.013
关键词
Gangliosides; Lipids; Metabolic disease; Sphingolipids; Sphingolipidoses
Sphingolipid and glycosphingolipid levels and expression of sphingolipid metabolizing enzymes are altered in a variety of diseases or in response to drug treatment. Inherited defects of enzymes and other proteins required for the lysosomal degradation of these lipids lead to human sphingolipidoses. Also genetic defects that affect sphingolipid biosynthesis are known. Although the molecular details are often far from clear, (glyco)sphingolipids have been implicated to play a role in atherosclerosis, insulin resistance, cancer, and infections by pathogens. More general aspects of selected diseases are discussed. (C) 2011 Elsevier Ireland Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据